Ispire Technology Inc. · NASDAQ:ISPR
Ispire Technology — Investor Presentation (September 2023)
21 slides from Ispire Technology's investor presentation, Sep 26, 2023
Slide 1: Ispire Technology, Inc. Management Presentation September 2023
Ispire Technology, Inc. (NASDAQ: ISPR) Management Presentation September 2023
Slide 2: Disclaimer
This presentation (this “Presentation”) has been prepared by Ispire Technology Inc . (the “Company”) solely for informational purposes . The information included herein in this Presentation has not been independently verified . No representations, warranties or undertakings, express or implied, are
Slide 3: Disclaimer (Continued)
These forward - looking statements involve known and unknown risks and uncertainties and are based on current expectations, assumptions, estimates and projections about the Company and the industry . The Company undertakes no obligation to update forward - looking statements to reflect subsequent oc
Slide 4: Investment Highlights
Industry Leading Vaping Tech Company Traded in the US Stock Exchange Large and Rapidly Growing Markets Industry Leading Innovations Globally Recognized Consumer Brand Deep Bench of Industry Veterans in Management Investment Highlights
Slide 5: Company Overview
Strong R&D Capabilities +15 Years of experience +200 Core patents Company Overview Extensive Distribution Network (Tobacco Products Only) +150 Distributors +30 Countries Cannabis Products Marketed under “Ispire” brand name, primarily on an ODM basis, cannabis vaping hardware sales currently are only
Slide 6: Corporate Structure
Ispire International Limited (British Virgin Islands) Aspire Science and Technology Limited (HK) Aspire North America LLC (California .U.S.) 100% 100% 100% Ispire Technology Inc. (Delaware. U.S.) » Ispire Technology Inc. (the Company) is incorporated in Delaware on June 13, 2022. » Aspire North Amer
Slide 7: Our Technology: Disrupting the Cannabis Vaping Market
Proprietary Technology Patented dual coil and airflow system technology enables users to create massive plumes of vape without burning the cannabis oil and eliminates the leakage of the oil from the unit, which we believe could provide the best - in - class airflow and taste Our Technology : Disrupt
Slide 8: History of Industry Driving Innovation
2010 2013 airflow adjustable tank Nautilus (Mini) 2014 Sub - Ohm tank Atlantis 2015 tank without chimney Cleito series 2017 Hot selling pod system with auto - draw Breeze series 2018 Leak free and liquid Isolating technology Closed System 2020 Cannabis first dual coil vaporizer DuCore 2021 Single -
Slide 9: Sales and Distribution
Cannabis Products x Sold directly by Ispire sales team in California, primarily on an ODM basis x All sales to date have been in the United States, commenced marketing efforts in Canada and Europe, primarily in the European Union Europe FY23: 50.8% FY22: 58.9% FY21: 71.8% Asia Pacific FY23: 12.9% FY
Slide 10: Regulatory Environment Provides Tailwinds for Growth
Regulatory Environment Provides Tailwinds for Growth The Department of Health and Human Services has recommended the Drug Enforcement Agency to move cannabis to Schedule 3 from Schedule I . Analysts expect the DEA to heed the recommendation in a few months . … The current tax treatment had a cash im
Slide 11: Cannabis legalization timeline
Source: Wikipedia 1996 California became the first state to legalize medical cannabis 2014 ▪ Alaska, Oregon along with Washington D.C. legalized the recreational use of marijuana ▪ Indian Reservation legalization allowed 2016 ▪ Four more states are legalized, including California, Nevada, Massachuse
Slide 12: Growth Potential for Cannabis Markets
3.1 4.7 6.5 8.7 13.0 20.0 27.0 33.0 38.8 43.8 48.3 0 10 20 30 40 50 2015 2016 2017 2018 2019 2020 2021 2022E 2023E 2024E 2025E Projected US Cannabis Market 2015 – 2025E (Retail Value) (1) Market Size of Cannabis Vapor Products 2020 – 2025E (Retail Value) (1) in USD billions in USD billions 3.9 6.1 7
Slide 13: US Ispire Cannabis Vaping Hardware Current US Market TAM
US Ispire Cannabis Vaping Hardware ---- Current US Market TAM US TAM = $6.1B (1) SAM = $2B (Hardware) Current Penetration = $40.0M • Cannabis/CBD vaping total addressable market is projected at $9.6 billion in 2025 (1) with expected penetration from $250M - $280M, approximately 8 - 9% of SAM • Canna
Slide 14: Globally Recognized Tobacco Vaping Brand
We are a well - known brand in Europe & US x Tobacco products are marketed and sold in over 30 countries x Our social media strategies aim to increase brand awareness; synergy across all platforms, including Instagram, Facebook and YouTube, following 21+ age verification guidelines x Through social
Slide 15: Bench of Industry Veterans
Tuanfang Liu | Co - Chief Executive Officer & Chairman ▪ Over 14 years of experience in research and development of the e - cigarette products and quality control management. ▪ Mr. Liu founded Shenzhen Yi Jia in 2010 and has served as its Chairman since then. ▪ Mr. Liu is responsible for daily opera
Slide 16: Financial Performance
Financial Performance (in USD mm) FY23 FY22 FY21 75.6 68.1 61.3 Tobacco Revenue 40.0 19.9 2.1 Cannabis Revenue 115.6 88.0 63.4 Total Revenue 21.0 13.3 10.4 Gross Profit 18.2% 15.1% 16.4% Gross Margin % 40.3 74.4 85.2 Cash
Slide 17: Financial Overview
$61.2 $68.1 $75.6 $2.1 $20.0 $40.0 $0 $10 $20 $30 $40 $50 $60 $70 $80 FY21 FY22 FY23 Revenue Breakdown by Product Types Tabacco Products Cannabis Products $9.9 $10.6 $11.8 $0.4 $2.6 $9.1 $0 $2 $4 $6 $8 $10 $12 $14 FY21 FY22 FY23 Gross Profit by Product Type Tabacco Products Cannabis Products (All fi
Slide 18: Investor Relations & Media Contact
Daniel Machock Chief Financial Officer Ispire Technologies Inc. ir@getispire.com Investor Relations & Media Contact
Slide 19: Appendix
| Appendix
Slide 20: Cannabis & Tobacco Outlook
Ispire is providing the following outlook for the cannabis and tobacco vaping products for the fiscal year of 2024, which ends on June 30, 2024. • Revenue from cannabis and tobacco vaping products was $40.0 million and $75.6 Million respectively for the fiscal year 2023 • Revenue for cannabis vaping
Slide 21: Non-GAAP Net Income/Loss Reconciliation
FY2022 FY2023 288,124 (4,512,513) Net (LOSS)/INCOME for Q1 - Q3 (2,162,277) (1,586,090) NET LOSS for Q4 - 175,304 Income Tax + 226,205 47,216 IPO related expenses that's not used to offset proceeds + - 1,103,058 Allowance for doubtful accounts + - 498,446 HK patent legal expense + - 238,152 US paten
Ispire Technology — Investor Presentation (September 2023) on 6ix